Perpetual Medicines Raises $8M in Seed Round for Peptide Drug Discovery Platform

Perpetual Medicines  announced it has closed an $8 million seed financing to advance its integrated computational design and synthesis platform for pe...

December 04, 2023 | Monday | News
Beyond Medtech: Healthcare+ Expo Taiwan Sets New Stage for Global Innovation in Future AI Healthcare

The Healthcare+ Expo Taiwan, currently taking place at Nangang Exhibition Hall 1 from November 30 to December 3, 2023, is poised to redefine the landscape ...

December 04, 2023 | Monday | News
Merck Expands Newest Biologics Testing Center in Shanghai

Further develops its biosafety testing laboratories to meet local demand New labs complete 2nd phase of company’s € 29 million Biologics Test...

November 29, 2023 | Wednesday | News
Samsung Biologics engages suppliers to advance global decarbonization targets

The company invited supplier companies and external ESG specialists to discuss ESG-related requirements and recommendations as well as share successful cas...

November 28, 2023 | Tuesday | News
Spineway Expands Global Reach with VEOS Implant Rollout in Spain, Colombia, and Indonesia

Successful First Implants in Spain, Accelerating Market Penetration New Approvals in Colombia and Indonesia Boost Sales Prospects Spineway Advances as ...

November 27, 2023 | Monday | News
Surge in Respiratory Illness Overwhelms Chinese Hospitals, WHO Requests Data

A wave of respiratory illnesses, accompanied by alarming clusters of pneumonia cases, has inundated hospitals in northern China, sparking deep concerns abo...

November 25, 2023 | Saturday | News
Seegene Boosts ESG Rating by Korea Institute of Corporate Governance and Sustainability

Seegene Inc. (KQ096530), a leading South Korean company providing a total solution for PCR molecular diagnostics, announced on November 10 that it has rece...

November 24, 2023 | Friday | News
STADA strikes partnership with CR Sanjiu in China to drive growth of its cough and cold portfolio

Partnership agreement signed on 22 November to broaden distribution and promotion of cough and cold brands such as Shidagong, Gelite and Ruike in China&n...

November 24, 2023 | Friday | News
Junshi Biosciences' VV116 COVID-19 Treatment Hits Lancet Infectious Diseases in Phase 3 Study Results

The paper presents final analysis results from a multicenter, double-blind, phase 3, randomized controlled study (NCT05582629) evaluating the efficacy and ...

November 24, 2023 | Friday | News
CMI Inc. and Life Molecular Imaging Secure Reimbursement for Amyloid-PET Diagnostic Neuraceq® in Japan

CMI Inc. and Life Molecular Imaging (LMI) are pleased to announce that the amyloid-PET diagnostic  Neuraceq® (florbetaben 18F injection) has ...

November 23, 2023 | Thursday | News
Wipro and NVIDIA Collaborate to Integrate Generative AI into Healthcare Insurance

Wipro Limited  a leading technology services and consulting company, today announced a collaboration with NVIDIA to help healthcare companies accelera...

November 22, 2023 | Wednesday | News
AstraZeneca's Global Initiative Surpasses 1 Million Lives Touched in the Fight Against Lung Cancer

Major Milestone Met in AI-Powered Fight Against Lung Cancer Global initiative gains significant ground in digitally identifying cancer risk before s...

November 22, 2023 | Wednesday | News
Mass General Brigham's Genetic Disease Center Launches Global Genomic Medicine Training in UAE

Genomic medicine, also known as precision medicine, offers transformative opportunities to reshape health care and public health from a 'one size fits all'...

November 21, 2023 | Tuesday | News
Apollomics Announces the First Approval of Vebreltinib for MET Exon 14 Skip Non-Small Cell Lung Cancer

"The NMPA approval of vebreltinib is an important milestone toward providing a new treatment option for patients with MET exon 14 skipping NSCLC in China. ...

November 17, 2023 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2023 Biopharma Boardroom. All Rights Reserved.


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in